# OnCo record radiopharm-theranostics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/radiopharm-theranostics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "radiopharm-theranostics" ;
  schema:name "Radiopharm Theranostics"@en ;
  schema:alternateName "Radiopharm Theranostics, Ltd"@en ;
  schema:description "Radiopharm Theranostics is an Australia-based radiopharmaceutical company that leads 3 cancer trials in OnCo, testing the radiopharmaceuticals 161Tb-RAD402, 177Lu-BetaBart and the PET tracer RAD101 in prostate cancer, colorectal cancer, non-small-cell lung cancer and ovarian cancer."@en ;
  schema:url <https://onco.cc/companies/radiopharm-theranostics/>, <https://radiopharmtheranostics.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://radiopharmtheranostics.com/>, <https://clinicaltrials.gov/search?lead=Radiopharm%20Theranostics%2C%20Ltd> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "AU" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/brain-tumours/> ;
  onco:trials <https://onco.cc/trials/nct07189871/>, <https://onco.cc/trials/nct07259213/>, <https://onco.cc/trials/nct06777433/> .